Evidence map›Paper›PMID 26318045›Full record

ArticleOncotarget2015

Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2.

Shingo Inaguma, Hideaki Ito, Miho Riku, Hiroshi Ikeda, Kenji Kasai

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Hedgehog Signaling: Implications in Cancers and Viral Infections.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shingo InagumaDepartment of Pathology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Hideaki ItoDepartment of Pathology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Miho RikuDepartment of Pathology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Hiroshi IkedaDepartment of Pathology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Kenji KasaiDepartment of Pathology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Aichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activity of GLI transcription factors of Hedgehog signaling is key for various cancer cell properties, especially in pancreatic ductal adenocarcinoma (PDAC). Zinc-finger transcriptional regulators ZIC1 to ZIC5 of ZIC gene family were demonstrated to associate with GLI to increase the nuclear accumulation and transcriptional activity of GLI. Notwithstanding this supportive role for GLI-dependent transcription, it was not fully understood whether ZIC plays an independent role in cancer cell biology. Here, we found that ZIC2 is indispensable in the regulation of PDAC cell apoptosis. We found that human PDAC cell lines uniquely express ZIC2. ZIC2 knockdown induced PDAC cell apoptosis; conversely, ZIC2 over-expression enhanced the cellular proliferation. Through a comprehensive screening, we identified fibroblast growth factor receptor 3 (FGFR3) and ANNEXIN A8 (ANXA8) as genes up-regulated by ZIC2 in PDAC cells. The forced expression of these two genes cooperatively rescued the apoptosis of ZIC2-knockdown cells. Immunohistochemical analyses further supported the correlation of ZIC2 expression and these genes in human pancreata harboring PDAC. Intriguingly, the ZIC2-mediated up-regulation of FGFR3 and ANXA8 was indicated to be GLI -independent. This evidence highlights the indispensable role of ZIC2 in regulating cellular proliferation and apoptosis during PDAC development and suggests a potential therapeutic target for PDAC.

Indexed as

Gene Expression ProfilingGene Expression Regulation, NeoplasticAnnexinsApoptosisCarcinoma, Pancreatic DuctalCell AdhesionCell LineCell Line, TumorCell ProliferationHumansImmunoblottingImmunohistochemistryNuclear ProteinsOligonucleotide Array Sequence AnalysisPancreatic NeoplasmsReceptor, Fibroblast Growth Factor, Type 3AnnexinsFGFR3 protein, humanGLI1 protein, humanNuclear ProteinsReceptor, Fibroblast Growth Factor, Type 3Transcription FactorsZIC2 protein, humanZinc Finger Protein GLI1ANXA8apoptosisFGFR3GLI1ZIC2

Identifiers

PMID26318045
PMCPMC4695058
OpenAlexW2167890106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.